She specializes in advanced, quantitative neuroimaging methods. She obtained her doctoral degree from Brigham Young University, completing postdoctoral training at Stanford University before joining the Stanford faculty in 2007. She joined the MD Anderson faculty in 2014. Dr. Kesler is interested in the neurotoxic effects of cancer therapies. She has pioneered the application of advanced neuroscience methods including connectomics and machine learning to the characterization of chemotherapy-related brain injury with the aim of identifying diagnostic and prognostic biomarkers. She investigates these biomarkers in both humans and animals. Her research, which focuses on breast cancer, has broad implications for cognitive neuroscience in terms of the intersection between aging, disease and neurodegeneration. Dr. Kesler is involved in both preclinical and clinical trials.